Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bioelectronics Corp BIEL

BioElectronics Corporation is an electroceutical company. The Company develops wearables, neuromodulation devices to mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulate electrical activity of the nervous system. Its product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and... see more

Recent & Breaking News (PINL:BIEL)

UPDATE - Letter from BioElectronics' (OTC PINK: BIEL) President to Investors

Marketwired August 29, 2017

Letter from BioElectronics' (OTC PINK: BIEL) President to Investors

Marketwired August 28, 2017

UPDATE - BioElectronics' President Discusses Company's Many Opportunities

Marketwired August 22, 2017

BioElectronics' President Discusses Company's Many Opportunities

Marketwired August 22, 2017

BioElectronics Engages Keith Nalepka As Vice President of Sales and Marketing

Marketwired August 22, 2017

BioElectronics Announces Update on Migraine Clinical Study Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

Marketwired August 8, 2017

BioElectronics Wins the Orthopedics This Week 2017 Sports Medicine Technology Award

Marketwired August 2, 2017

BioElectronics to Present at 2017 UK Community Pharmacists' Meeting

Marketwired June 30, 2017

BioElectronics Announces Health Economics Study

Marketwired June 29, 2017

BioElectronics Announces Independent Migraine Clinical Study; Migraine Prevention Using ActiPatch (Pulsed Shortwave Therapy)

Marketwired May 30, 2017

BioElectronics Expands into Tesco in the UK Market

Marketwired May 17, 2017

BioElectronics President Interviewed By UpTick Radio: A Discussion on how Wearable Technology can Mitigate the Opioid Addiction Crisis

Marketwired April 20, 2017

BioElectronics to Present Research at 13th World Congress of International Neuromodulation Society

Marketwired April 11, 2017

BioElectronics Participates At 2017 Australian Pain Society 37th Annual Scientific Meeting

Marketwired April 7, 2017

BioElectronics' ActiPatch Exhibits At Australia's Major Pharmaceutical Event

Marketwired March 13, 2017

BioElectronics Appoints an Indian Subcontinent Distributor

Marketwired March 6, 2017

BioElectronics Initiates US Over-the-Counter (Non Prescription) Sales Of Its FDA Cleared Drug-free Pain Relief Medical Devices

Marketwired March 2, 2017

BioElectronics Corporation Letter from the President

Marketwired February 28, 2017

BioElectronics Announces ActiPatch(R) Available on Amazon

Marketwired February 9, 2017

BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch(R) Musculoskeletal Pain Therapy

Marketwired February 6, 2017